Bumper Offer - Urjas oil Just @ Rs. 1 X
Betanif 50/20 Tablet is a prescription medicine that is available as a Tablet. Betanif 50/20 Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Betanif 50/20 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Betanif 50/20 Tablet include Blurred vision, Cold hands. Apart from the aforementioned side effects, Betanif 50/20 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Betanif 50/20 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Betanif 50/20 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Betanif 50/20 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Betanif 50/20 Tablet related warnings section.
Betanif 50/20 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Low Blood Pressure (Hypotension), Asthma are examples of such conditions. Some other conditions that can be affected by Betanif 50/20 Tablet are listed in the contraindications section below.
Drug reaction of Betanif 50/20 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Betanif 50/20 Tablet is not safe while driving, and is is not addictive in nature.
Betanif 50/20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Betanif 50/20 Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Betanif 50/20 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Betanif. If you are pregnant, do not take Betanif without a doctor's advice.
Is the use of Betanif 50/20 Tablet safe during breastfeeding?
Betanif should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Betanif 50/20 Tablet on the Kidneys?
There are no side effects of Betanif on the kidneys.
What is the effect of Betanif 50/20 Tablet on the Liver?
Side effects of Betanif rarely affect the liver.
What is the effect of Betanif 50/20 Tablet on the Heart?
Side effects of Betanif on heart are unknown because research on this has not been conducted yet.
Betanif 50/20 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Betanif 50/20 Tablet unless your doctor advises you to do so -
Is this Betanif 50/20 Tablet habit forming or addictive?
Betanif 50/20 Tablet does not cause addiction.
Interaction between Food and Betanif 50/20 Tablet
Some foods when eaten with Betanif 50/20 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Betanif 50/20 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Betanif 50/20 Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Procardia XL® (nifedipine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 549
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 907-909